Quarterly Results

DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE195.6010.6 (+5.73 %)
PREV CLOSE ( ) 185.00
OPEN PRICE ( ) 192.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14045
TODAY'S LOW / HIGH ( )192.10 197.55
52 WK LOW / HIGH ( )132.75 307.8
NSE195.3310.26 (+5.54 %)
PREV CLOSE( ) 185.07
OPEN PRICE ( ) 191.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 235983
TODAY'S LOW / HIGH( ) 191.90 198.00
52 WK LOW / HIGH ( )133 307.98
Quarters
Select year  
( in Million)
Particulars
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
6823.4
7890.4
5237.8
6547.1
Total Expenditure
5422.1
6418.9
4948.1
5920.3
PBIDT (Excl OI)
1401.3
1471.5
289.7
626.8
Other Income
56.3
66.5
14.3
71.6
Operating Profit
1457.6
1538
304
698.4
Interest
487.8
366.3
319.3
309.5
Exceptional Items
20.4
-29.6
-54.4
-30.9
PBDT
990.19
1142.1
-69.7
358
Depreciation
719.7
720.9
705.9
850
Profit Before Tax
270.49
421.19
-775.6
-492
Tax
224.2
90.3
0.1
207.2
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
46.29
330.89
-775.7
-699.2
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
46.29
330.89
-775.7
-699.2
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
46.3
330.9
-775.7
-699.2
Equity Capital
313.6
313.6
313.6
313.6
Face Value (IN RS)
2
2
2
2
Reserves
NA
NA
NA
NA
Calculated EPS
0.29
2.11
-4.94
-4.45
Calculated EPS (Annualised)
1.18
8.44
-19.78
-17.83
No of Public Share Holdings
63775653
63775653
63775653
63775653
% of Public Share Holdings
40.68
40.68
40.68
40.68
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
20.53
18.64
5.53
9.57
PBIDTM%
21.36
19.49
5.80
10.66
PBDTM%
14.51
14.47
-1.33
5.46
PBTM%
3.96
5.33
-14.80
-7.51
PATM%
0.67
4.19
-14.80
-10.67
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.